Monthly Archives: January 2009

Home/2009/January

Plasma level testing: what we know, what we don’t & what we hope to learn

This month, Novartis Pharmaceuticals (maker of Gleevec) launched a new website designed to help optimize the outcome of GIST patients taking Gleevec. Some of the featured content is about blood level testing for GIST. In addition, the website prominently links to the Avantix labs website (www.bloodleveltesting.com) for testing Gleevec blood levels in CML and GIST.

By |2019-04-08T08:52:11-04:00January 28th, 2009|News, Research, Survival Strategies|

GIST Member Story – Michelle Presnall

During my teenage years I experienced a lot of stomach problems. In 1988 I was traveling in the US when a doctor visit led to the discovery of a 6cm x 9cm tumor in my stomach. I had a laporotomy at Panarama Community Hospital in Los Angeles, and was sent home to Sydney, Australia for my recovery. At the time, my diagnosis was leiomyoma with an uncertain malignant potential. Within three months, the tumor was back and had doubled in size and in pain. The next year I had a partial gastrectomy which removed the tumor and the top half of my stomach. This was a huge operation that nearly cost me my life.

By |2019-12-30T09:49:45-05:00January 11th, 2009|Member Stories|

Treatment Strategies & Mutational Testing among Key Topics at CTOS 2008

Treatment strategies & mutational testing were among key topics at CTOS 2008. There were also other  presentations and posters regarding GIST were presented at the Connective Tissue Oncology Society (CTOS) meeting on November 13 to [...]

By |2019-04-05T10:52:32-04:00January 1st, 2009|Mutational Testing, News, Survival Strategies|
Go to Top